Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Vaccination is one of the most effective methods available to prevent infectious diseases. Mucosa, which are exposed to heavy loads of commensal and pathogenic microorganisms,are one of the first areas where infections are established,and therefore have frontline status in immunity, making mucosa ideal sites for vaccine application. Moreover, vaccination through the mucosal immune system could induce effective systemic immune responses together with mucosal immunity in contrast to parenteral vaccination, which is a poor inducer of effective immunity at mucosal surfaces. Among mucosal vaccines, oral mucosal vaccines have the advantages of ease and low cost of vaccine administration. The oral mucosal immune system, however, is generally recognized as poorly immunogenic due to the frequent induction of tolerance against orally-introduced antigens. Consequently,a prerequisite for successful mucosal vaccination is that the orally introduced antigen should be transported across the mucosal surface into the mucosa-associated lymphoid tissue (MALT). In particular, M cells are responsible for antigen uptake into MALT, and the rapid and effective transcytotic activity of M cells makes them an attractive target for mucosal vaccine delivery, although simple transport of the antigen into M cells does not guarantee the induction of specific immune responses. Consequently, development of mucosal vaccine adjuvants based on an understanding of the biology of M cells has attracted much research interest. Here, we review the characteristics of the oral mucosal immune system and delineate strategies to design effective oral mucosal vaccines with an emphasis on mucosal vaccine adjuvants.
Abstract
Vaccination is one of the most effective methods available to prevent infectious diseases. Mucosa, which are exposed to heavy loads of commensal and pathogenic microorganisms,are one of the first areas where infections are established,and therefore have frontline status in immunity, making mucosa ideal sites for vaccine application. Moreover, vaccination through the mucosal immune system could induce effective systemic immune responses together with mucosal immunity in contrast to parenteral vaccination, which is a poor inducer of effective immunity at mucosal surfaces. Among mucosal vaccines, oral mucosal vaccines have the advantages of ease and low cost of vaccine administration. The oral mucosal immune system, however, is generally recognized as poorly immunogenic due to the frequent induction of tolerance against orally-introduced antigens. Consequently,a prerequisite for successful mucosal vaccination is that the orally introduced antigen should be transported across the mucosal surface into the mucosa-associated lymphoid tissue (MALT). In particular, M cells are responsible for antigen uptake into MALT, and the rapid and effective transcytotic activity of M cells makes them an attractive target for mucosal vaccine delivery, although simple transport of the antigen into M cells does not guarantee the induction of specific immune responses. Consequently, development of mucosal vaccine adjuvants based on an understanding of the biology of M cells has attracted much research interest. Here, we review the characteristics of the oral mucosal immune system and delineate strategies to design effective oral mucosal vaccines with an emphasis on mucosal vaccine adjuvants.
참고문헌 (82)
- Almond, J. W., "Vaccine renaissance", Nat. Rev. Microbiol, 5, pp.478~481 (2007)
- Rappuoli, R, "Vaccines for the twenty-first century society", Nat. Rev.Immunol, 11, pp.865~872 (2011)
- Mitragotri, S., "Immunization without needles", Nat. Rev. Immunol, 5, pp.905~916 (2005)
- Chen, K, "Vaccination strategies to promote mucosal antibody responses", Immunity, 33, pp.479~491 (2010)
- Shin, S., "Oral vaccines against cholera", Clin. Infect. Dis, 52, pp.1343~1349 (2011)
- Czerkinsky, C, "Enteric vaccines for the developing world: a challenge for mucosal immunology", Mucosal Immunol, 2, pp.284~287 (2009)
- Pasetti, M. F., "Immunology of gut mucosal vaccines", Immunol. Rev, 239, pp.125~148 (2011)
- Weiner, H. L., "Oral tolerance", Immunol. Rev, 241, pp.241~259 (2011)
- Lycke, N, "Recent progress in mucosal vaccine development: potential and limitations", Nat. Rev. Immunol, 12, pp.592~605 (2012)
- Ogra, P. L, "Mucosal immunity: some historical perspective on host-pathogen interactions and implications for mucosal vaccines", Immunol. Cell. Biol, 81, pp.23~33 (2003)
- Artis, D, "Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut", Nat. Rev. Immunol, 8, pp.411~420 (2008)
- Wells, J. M., "Epithelial crosstalk at the microbiota-mucosal interface", Proc. Natl. Acad. Sci. USA, 108(Suppl 1), pp.4607~4614 (2011)
- Iwasaki, A., "Mucosal dendritic cells", Annu. Rev. Immunol, 25, pp.381~418 (2007)
- McGuckin, M. A., "Mucin dynamics and enteric pathogens", Nat. Rev.Microbiol, 9, pp.265~278 (2011)
- Laurie Glimcher, "Homeostasis and Inflammation in the Intestine", CELL, 140(6), pp.859~870, CELL PRESS
- Heazlewood, C. K, "Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis", PLoS Med, 5, pp.e54~ (2008)
- Biton, M., "Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk", Nat. Immunol, 12, pp.239~246 (2011)
- Bevins, C. L., "Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis", Nat. Rev. Microbiol, 9, pp.356~368 (2011)
- Kaser, A., ""ER stress(ed out)!": Paneth cells and ischemia-reperfusion injury of the small intestine", Gastroenterology, 140, pp.393~396 (2011)
- Niederreiter, L., "Endoplasmic reticulum stress and inflammatory bowel disease", Acta Gastroenterol. Belg, 74, pp.330~333 (2011)
- Iliev, I. D., "Intestinal epithelial cells promote colitis- protective regulatory T-cell differentiation through dendritic cell conditioning", Mucosal Immunol, 2, pp.340~350 (2009)
- Rimoldi, M., "Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells", Nat. Immunol, 6, pp.507~514 (2005)
- He, B., "Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL", Immunity, 26, pp.812~826 (2007)
- Kyd, J. M, "Functional differences between M cells and enterocytes in sampling luminal antigens", Vaccine, 26, pp.6221~6224 (2008)
- Jang, M. H., "Intestinal villous M cells: an antigen entry site in the mucosal epithelium", Proc. Natl. Acad. Sci. USA, 101, pp.6110~6115 (2004)
- Corr, S. C., "M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis", FEMS Immunol. Med. Microbiol, 52, pp.2~12 (2008)
- Owen, R. L, "Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles", Gastroenterology, 66, pp.189~203 (1974)
- Heath, J. P, "Epithelial cell migration in the intestine", Cell. Biol. Int, 20, pp.139~146 (1996)
- Gebert, A., "The development of M cells in Peyer's patches is restrictedto specialized dome-associated crypts", Am. J. Pathol, 154, pp.1573~1582 (1999)
- Hsieh, E. H., "CD137 is required for M cell functional maturation but not lineage commitment", Am. J. Pathol, 177, pp.666~676 (2010)
- Knoop, K. A., "RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium", J. Immunol, 183, pp.5738~5747 (2009)
- Mach, J., "Development of intestinal M cells", Immunol. Rev, 206, pp.177~189 (2005)
- Clark, M. A, "Intestinal M cells and their role in bacterial infection", Int. J. Med. Microbiol, 293, pp.17~39 (2003)
- Pickard, J. M, "Sampling of the intestinal microbiota by epithelial M cells", Curr. Gastroenterol. Rep, 12, pp.331~339 (2010)
- Azizi, A., "Enhancing oral vaccine potency by targeting intestinal M cells", PLoS Pathog, 6, pp.e1001147~ (2010)
- Finzi, G., "Cathepsin E in follicle associated epithelium of intestine and tonsils: localization to M cells and possible role in antigen processing", Histochemistry, 99, pp.201~211 (1993)
- Kernéis, S., "Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria", Science, 277, pp.949~952 (1997)
- Gullberg, E., "Expression of specific markers and particle transport in a new human intestinal M-cell model", Biochem. Biophys. Res. Commun, 279, pp.808~813 (2000)
- Brandtzaeg, P., "Terminology: nomenclature of mucosa-associated lymphoidtissue", Mucosal Immunol, 1, pp.31~37 (2008)
- Brandtzaeg, P., "Mucosal immunity: induction, dissemination, and effector functions", Scand. J. Immunol, 70, pp.505~515 (2009)
- Otczyk, D. C., "Mucosal immunization: a realistic alternative", Hum. Vaccin, 6, pp.978~1006 (2010)
- Bemark, M., "Induction of gut IgA production through T cell-dependent and T cell-independent pathways", Ann. N. Y. Acad. Sci, 1247, pp.97~116 (2012)
- Strugnell, R. A., "The role of secretory antibodies in infection immunity", Nat. Rev. Microbiol, 8, pp.656~667 (2010)
- Cerutti, A., "Immunoglobulin responses at the mucosal interface", Annu. Rev. Immunol, 29, pp.273~293 (2011)
- Hoft, D. F, V. Brusic, "Optimizing vaccine development", Cell. Microbiol, 13, pp.934~942 (2011)
- McAleer, J. P., "Mechanisms controlling Th17 cytokine expression and host defense", J. Leukoc. Biol, 90, pp.263~270 (2011)
- Blaschitz, C, "Th17 cytokines and the gut mucosal barrier", J. Clin. Immunol, 30, pp.196~203 (2010)
- Sheridan, B. S., "Regional and mucosal memory T cells", Nat. Immunol, 12, pp.485~491 (2011)
- Borges, O., "Mucosal vaccines: recent progress in understanding the natural barriers", Pharm. Res, 27, pp.211~223 (2010)
- 우소연, "Oral Tolerance Increased the Proportion of CD8＋ T Cells in Mouse Intestinal Lamina Propria", Immune Network, 8(2), pp.46~52 (2008), 대한면역학회
- Rescigno, M., "Interactions among dendritic cells, macrophages, and epithelial cells in the gut: implications for immune tolerance", Curr. Opin. Immunol, 20, pp.669~675 (2008)
- Czerkinsky, C., "Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues", Curr. Top. Microbiol. Immunol, 354, pp.1~18 (2012)
- Mora, J. R, "Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells", Science, 314, pp.1157~1160 (2006)
- Iwata, M., "Retinoic acid imprints gut-homing specificity on T cells", Immunity, 21, pp.527~538 (2004)
- Pavot, V., "New insights in mucosal vaccine development", Vaccine, 30, pp.142~154 (2012)
- Mestecky, J., "Oral immunization: an update", Curr. Opin. Gastroenterol, 24, pp.713~719 (2008)
- Sturm, J. T, "The prevalence of Neisseria gonorrhoeae and Chlamydia trachomatis in victims of sexual assault", Ann. Emerg. Med, 19, pp.587~590 (1990)
- Streatfield, S. J., "Plant-based vaccines", Int. J. Parasitol, 33, pp.479~493 (2003)
- Walmsley, A. M, "Plants for delivery of edible vaccines", Curr. Opin. Biotechnol, 11, pp.126~129 (2000)
- Haq, T. A., "Oral immunization with a recombinant bacterial antigenproduced in transgenic plants", Science, 268, pp.714~716 (1995)
- Yuki, Y., "Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity", Vaccine, 27, pp.5982~5988 (2009)
- Coffman, R. L., "Vaccine adjuvants: putting innate immunity to work", Immunity, 33, pp.492~503 (2010)
- Reed, S. G., "New horizons in adjuvants for vaccine development", Trends Immunol, 30, pp.23~32 (2009)
- Babai, I., "A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin", neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice, 1999, pp.17, 1239~1250
- Kuolee, R., "M cell-targeted delivery of vaccines and therapeutics", Expert Opin. Drug. Deliv, 5, pp.693~702 (2008)
- Gebert, A., "M cells in Peyer's patches of the intestine", Int. Rev. Cytol, 167, pp.91~159 (1996)
- Foster, N., "Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo", Vaccine, 16, pp.536~541 (1998)
- Clark, M. A, "Differential surface characteristics of M cells frommouse intestinal Peyer's and caecal patches", Histochem. J, 26, pp.271~280 (1994)
- Gupta, P. N., "M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B", J. Drug. Target, 15, pp.701~713 (2007)
- Clark, M. A., "Targeting polymerised liposome vaccine carriers to intestinal M cells", Vaccine, 20, pp.208~217 (2001)
- Devriendt, B, "Crossing the barrier: Targeting epithelial receptors forenhanced oral vaccine delivery", J. Control Release, 160, pp.431~439 (2012)
- Nochi, T., "A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses", J. Exp. Med, 204, pp.2789~2796 (2007)
- Hirabayashi, J., "Oligosaccharide specificity of galectins: a search by frontal affinity chromatography", Biochim. Biophys. Acta, 1572, pp.232~254 (2002)
- Keely, S., "Hypoxia-inducible factor-dependent regulation of platelet-activating factor receptor as a route for gram-positive bacterial translocation across epithelia", Mol. Biol. Cell, 21, pp.538~546 (2010)
- Tyrer, P., "Microbial pattern recognition receptors mediate M-cell uptake of a gram-negative bacterium", Infect. Immun, 74, pp.625~631 (2006)
- Kim, S. H., "The M cell-targeting ligand promotes antigen deliveryand induces antigen-specific immune responses in mucosalvaccination", J. Immunol, 185, pp.5787~5795 (2010)
- Clark, M. A, "M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells", Infect. Immun, 66, pp.1237~1243 (1998)
- Wolf, J. L., "Determinants of reovirus interaction with the intestinal M cells and absorptive cells of murine intestine", Gastroenterology, 85, pp.291~300 (1983)
- Hase, K, "Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response", Nature, 462, pp.226~230 (2009)
- Nakato, G., "Cutting Edge: Brucella abortus exploits a cellular prion protein on intestinal M cells as an invasive receptor", J. Immunol, 189, pp.1540~1544 (2012)
- Kim, S. H, "M cells expressing the complement C5a receptor are efficient targets for mucosal vaccine delivery", Eur. J. Immunol, 41, pp.3219~3229 (2011)
- Kunisawa, J., "Gut-associated lymphoid tissues for the development of oral vaccines", Adv. Drug. Deliv. Rev, 64, pp.523~530 (2012)